Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: The effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines

Journal of Medicinal Chemistry

Volumn 39, Issue 18, 1996, Pages 3470-3476

  Renau, Thomas E ^a   Kennedy, Christopher ^b   Ptak, Roger G ^b   Breitenbach, Julie M ^b   Drach, John C ^b   Townsend, Leroy B ^b  

^a Microcide Pharmaceuticals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PYRROLOPYRIMIDINE DERIVATIVE; SANGIVAMYCIN DERIVATIVE; TOYOCAMYCIN DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG EFFECT; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; HERPESVIRUS 1, HUMAN; HUMANS; PYRIMIDINE NUCLEOSIDES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOSIDES; TOYOCAMYCIN;

EID: 0029838476     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950835y     Document Type: Article

References (16)

1. Renau, T. E.; Wotring, L. L.; Drach, J. C.; Townsend, L. B. Design of non-nucleoside analogs of toyocamycin, sangivamycin and thiosangivamycin: the influence of 7-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines. J. Med. Chem. 1996, 39, 873-880.
2. Rubin, R. H. Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 1990, 12 (Suppl. 7), 754-766.
3. Stratta, R. J.; Shaeffer, M. S.; Markin, R. S.; Wood, R. P.; Langnas, A. N.; Reed, E. C.; Donovan, J. P.; Woods, G. L.; Bradshaw, K. A.; Pillen, T. J.; Shaw, B. W., Jr. Cytomegalovirus infection disease after liver transplantation. Dig. Dis. Sci. 1992, 37, 673-688.
4. Mills, J.; Masur, H. AIDS-related infections. Sci. Am. 1990, 263, 50-57.
5. Peters, B. S.; Beck, E. J.; Anderson, S.; Coleman, D.; Coker, R.; Main, J.; Migdal, C.; Harris, J. R. W.; Pinching, A. J. Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival. J. Infect. 1991, 23, 129-137.
6. Schram, K. H.; Townsend, L. B. Pyrrolopyrimidine nucleosides. Part XI. Influence of amino groups at C-4 and C-6 or an amino group at C-6 on the reactivity of a cyano group in pyrrolo[2,3-d]pyrimidine nucleosides. J. Chem. Soc., Perkin Trans. 1 1975, 1253-1257.
7. Hinshaw, B. C.; Leonoudakis, O.; Schram, K.; Townsend, L. B. Pyrrolopyrimidine nucleosides. Part X. Synthesis of certain 4,5-disubstituted 7-(β-D-ribofuranosyl)-pyrrolo[2,3-d]pyrimidines related to toyocamycin and sangivamycin. J. Chem. Soc., Perkin Trans. I 1975, 1248-1253.
8. Hinshaw, B. C.; Gerster, J. F.; Robins, R. K.; Townsend, L. B. Pyrrolopyrimidine nucleosides. V. A study on the relative chemical reactivity of the 5-cyano group of the nucleoside antibiotic toyocamycin and desaminotoyocamycin. The synthesis of analogs of sangivamycin. J. Org. Chem. 1970, 35, 236-241.
9. Swayze, E. E.; Shannon, W. M.; Buckheit, R. W.; Wotring, L. L.; Drach, J. C.; Townsend, L. B. Synthesis, antiproliferative and antiviral evaluation of certain acyclic 6-substituted pyrrolo[2,3-d]pyrimidine nucleoside analogs related to sangivamycin and toyocamycin. Nucleosides Nucleotides 1992, 11, 1507-1527.
10. Renau, T. E.; Lee, J. S.; Kim, H.; Young, C. G.; Wotring, L. L.; Townsend, L. B.; Drach, J. C. Relationship between cytotoxicity and conversion of thiosangivamycin analogs to toyocamycin analogs in cell culture medium. Biochem. Pharmacol. 1994, 48, 801-807.
11. Unpublished data from our laboratories.
12. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzlinger, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
13. Prichard, M. N.; Shipman, C., Jr. A three dimensional model to analyze drug-drug interactions. Antiviral Res. 1990, 14, 181-206.
14. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C., Jr.; Drach, J. C. A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus. J. Virol. Methods 1990, 28, 101-106.
15. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob. Agents Chemother. 1991, 35, 1060-1065.
16. Wotring, L. L.; Townsend, L. B. Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(β-D-ribofuranosyl)-pyrazolo[3,4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase. Cancer Res. 1979, 39, 3018-3023.